{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T12:28:04Z","timestamp":1787056084963,"version":"build-2736575974"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","award":["202308210122"],"award-info":[{"award-number":["202308210122"]}],"id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.cellsig.2026.112764","type":"journal-article","created":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T13:18:24Z","timestamp":1785071904000},"page":"112764","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["miR-143-3p integrates contractility and growth in benign prostate stromal cells"],"prefix":"10.1016","volume":"147","author":[{"given":"Wenbin","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajie","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Ciotkowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Tamalunas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian G.","family":"Stief","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Hennenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 9","key":"10.1016\/j.cellsig.2026.112764_bb0005","first-page":"S3","article-title":"Pathophysiology, epidemiology, and natural history of benign prostatic hyperplasia","volume":"6","author":"Lepor","year":"2004","journal-title":"Rev. Urol."},{"key":"10.1016\/j.cellsig.2026.112764_bb0010","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1111\/j.1464-410X.2010.09993.x","article-title":"Worldwide prevalence estimates of lower urinary tract symptoms, overactive bladder, urinary incontinence and bladder outlet obstruction","volume":"108","author":"Irwin","year":"2011","journal-title":"BJU Int."},{"key":"10.1016\/j.cellsig.2026.112764_bb0015","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.eururo.2023.04.008","article-title":"Summary paper on the 2023 European Association of Urology Guidelines on the management of non-neurogenic male lower urinary tract symptoms","volume":"84","author":"Gravas","year":"2023","journal-title":"Eur. Urol."},{"key":"10.1016\/j.cellsig.2026.112764_bb0020","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/164_2023_678","article-title":"Adrenoceptors in the lower urinary tract","volume":"285","author":"Hennenberg","year":"2024","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.cellsig.2026.112764_bb0025","doi-asserted-by":"crossref","first-page":"6451","DOI":"10.1016\/j.cell.2024.10.024","article-title":"Small and long non-coding RNAs: past, present, and future","volume":"187","author":"Chen","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.cellsig.2026.112764_bb0030","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s00424-024-03053-5","article-title":"Nobel prize for physiology or medicine in 2024 for the discovery of microRNAs: small RNAs with fundamental roles in development and disease","volume":"477","author":"Qu\u00e9villon Huberdeau","year":"2025","journal-title":"Pflugers Arch."},{"key":"10.1016\/j.cellsig.2026.112764_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2021.110004","article-title":"The miR-223-3p\/MAP1B axis aggravates TGF-beta-induced proliferation and migration of BPH-1 cells","volume":"84","author":"Wang","year":"2021","journal-title":"Cell. Signal."},{"key":"10.1016\/j.cellsig.2026.112764_bb0040","doi-asserted-by":"crossref","first-page":"9442","DOI":"10.18632\/aging.102395","article-title":"Long noncoding RNA DNM3OS promotes prostate stromal cells transformation via the miR-29a\/29b\/COL3A1 and miR-361\/TGFbeta1 axes","volume":"11","author":"Wang","year":"2019","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.cellsig.2026.112764_bb0045","doi-asserted-by":"crossref","first-page":"643","DOI":"10.21037\/tau-20-1169","article-title":"LncRNA DIO3OS regulated by TGF-beta1 and resveratrol enhances epithelial mesenchymal transition of benign prostatic hyperplasia epithelial cells and proliferation of prostate stromal cells","volume":"10","author":"Chen","year":"2021","journal-title":"Transl. Androl. Urol."},{"key":"10.1016\/j.cellsig.2026.112764_bb0050","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.23391","article-title":"MIR663AHG as a competitive endogenous RNA regulating TGF-beta-induced epithelial proliferation and epithelial-mesenchymal transition in benign prostate hyperplasia","volume":"37","author":"Tong","year":"2023","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.cellsig.2026.112764_bb0055","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s12894-022-01121-5","article-title":"Upregulation of mir-1199-5p is associated with reduced type 2 5-alpha reductase expression in benign prostatic hyperplasia","volume":"22","author":"Liu","year":"2022","journal-title":"BMC Urol."},{"key":"10.1016\/j.cellsig.2026.112764_bb0060","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/CU9.0000000000000233","article-title":"Hypoxia activates the hypoxia-inducible factor-1\u03b1\/vascular endothelial growth factor pathway in a prostatic stromal cell line: a mechanism for the pathogenesis of benign prostatic hyperplasia","volume":"18","author":"Zhang","year":"2024","journal-title":"Curr. Urol."},{"key":"10.1016\/j.cellsig.2026.112764_bb0065","doi-asserted-by":"crossref","first-page":"e246","DOI":"10.5301\/jbm.5000069","article-title":"MicroRNAs 143 and 145 may be involved in benign prostatic hyperplasia pathogenesis through regulation of target genes and proteins","volume":"29","author":"Viana","year":"2014","journal-title":"Int. J. Biol. Markers"},{"key":"10.1016\/j.cellsig.2026.112764_bb0070","first-page":"675","article-title":"miR-1202 regulates BPH-1 cell proliferation, apoptosis, and epithelial-to-mesenchymal transition through targeting HMGCL","volume":"56","author":"Wang","year":"2024","journal-title":"Acta Biochim. Biophys. Sin. Shanghai"},{"key":"10.1016\/j.cellsig.2026.112764_bb0075","first-page":"3853","article-title":"MicroRNA expression profiles in benign prostatic hyperplasia","volume":"17","author":"Zhang","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.cellsig.2026.112764_bb0080","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.ijbiomac.2022.11.162","article-title":"Decoding ceRNA regulatory network and autophagy-related genes in benign prostatic hyperplasia","volume":"225","author":"Zhou","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.cellsig.2026.112764_bb0085","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/MS9.0000000000001498","article-title":"MicroRNAs (miRNAs) role in hypertension: pathogenesis and promising therapeutics","volume":"86","author":"Shaheen","year":"2024","journal-title":"Ann. Med. Surg. (Lond.)"},{"key":"10.1016\/j.cellsig.2026.112764_bb0090","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/s00018-023-04793-w","article-title":"MicroRNA regulation of phenotypic transformations in vascular smooth muscle: relevance to vascular remodeling","volume":"80","author":"Wang","year":"2023","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.cellsig.2026.112764_bb0095","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1172\/JCI38864","article-title":"Acquisition of the contractile phenotype by murine arterial smooth muscle cells depends on the Mir143\/145 gene cluster","volume":"119","author":"Boettger","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cellsig.2026.112764_bb0100","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1161\/ATVBAHA.117.310499","article-title":"Loss of vascular myogenic tone in miR-143\/145 knockout mice is associated with hypertension-induced vascular lesions in small mesenteric arteries","volume":"38","author":"Holmberg","year":"2018","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.cellsig.2026.112764_bb0105","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.70190","article-title":"Vasoactivity of Rac GTPase, Cytohesin and kinase inhibitors in renal interlobar and coronary arteries reveals shared and distinct patterns of inhibitory effects in vascular and prostate smooth muscle contraction","volume":"13","author":"Liu","year":"2025","journal-title":"Pharmacol. Res. Perspect."},{"key":"10.1016\/j.cellsig.2026.112764_bb0110","doi-asserted-by":"crossref","first-page":"5644","DOI":"10.1038\/s41598-025-90229-3","article-title":"Comprehensive analysis of the global, regional, and national burden of benign prostatic hyperplasia from 1990 to 2021","volume":"15","author":"Chen","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cellsig.2026.112764_bb0115","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12894-025-01715-9","article-title":"Global, regional, and national burden of benign prostatic hyperplasia from 1990 to 2021 and projection to 2035","volume":"25","author":"Wei","year":"2025","journal-title":"BMC Urol."},{"key":"10.1016\/j.cellsig.2026.112764_bb0120","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1093\/carcin\/20.7.1185","article-title":"A human prostatic stromal myofibroblast cell line WPMY-1: a model for stromal-epithelial interactions in prostatic neoplasia","volume":"20","author":"Webber","year":"1999","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.cellsig.2026.112764_bb0125","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1111\/bph.13099","article-title":"Inhibition of prostate smooth muscle contraction and prostate stromal cell growth by the inhibitors of Rac, NSC23766 and EHT1864","volume":"172","author":"Wang","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.cellsig.2026.112764_bb0130","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/BF02631333","article-title":"Establishment and characterization of an immortalized but non-transformed human prostate epithelial cell line: BPH-1","volume":"31","author":"Hayward","year":"1995","journal-title":"In Vitro Cell. Dev. Biol. Anim."},{"key":"10.1016\/j.cellsig.2026.112764_bb0135","doi-asserted-by":"crossref","first-page":"e23604","DOI":"10.1096\/fj.202400362R","article-title":"Isoform-independent promotion of contractility and proliferation, and suppression of survival by with no lysine\/K kinases in prostate stromal cells","volume":"38","author":"Liu","year":"2024","journal-title":"FASEB J."},{"key":"10.1016\/j.cellsig.2026.112764_bb0140","article-title":"Inhibition of growth and contraction in human prostate stromal cells by silencing of NUAK1 and \u22122, and by the presumed NUAK inhibitors HTH01-015 and WZ4003","volume":"14","author":"Liu","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.cellsig.2026.112764_bb0145","doi-asserted-by":"crossref","DOI":"10.1007\/s00345-025-05652-y","article-title":"Silencing of Rac1 and Arf6 reduces time-dependent and carbachol-induced contractions, proliferation, survival and growth in human bladder smooth muscle cells","volume":"43","author":"Qian","year":"2025","journal-title":"World. J. Urol."},{"key":"10.1016\/j.cellsig.2026.112764_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.121928","article-title":"Silencing of CDC42 inhibits contraction and growth-related functions in prostate stromal cells, which is mimicked by ML141","volume":"329","author":"Wang","year":"2023","journal-title":"Life Sci."},{"key":"10.1016\/j.cellsig.2026.112764_bb0155","doi-asserted-by":"crossref","DOI":"10.3390\/ph18121864","article-title":"Pine-extracted phytosterol \u03b2-Sitosterol (APOPROSTAT(\u00ae) forte) inhibits both human prostate smooth muscle contraction and prostate stromal cell growth, without cytotoxic effects: a mechanistic link to clinical efficacy in LUTS\/BPH","volume":"18","author":"Tamalunas","year":"2025","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.cellsig.2026.112764_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117066","article-title":"Immunomodulatory imide drugs inhibit human detrusor smooth muscle contraction and growth of human detrusor smooth muscle cells, and exhibit vaso-regulatory functions","volume":"177","author":"Tamalunas","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.cellsig.2026.112764_bb0165","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1124\/jpet.114.219170","article-title":"Common misconceptions about data analysis and statistics","volume":"351","author":"Motulsky","year":"2014","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.cellsig.2026.112764_bb0170","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1124\/mol.119.118927","article-title":"New author guidelines for displaying data and reporting data analysis and statistical methods in experimental biology","volume":"97","author":"Michel","year":"2020","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.cellsig.2026.112764_bb0175","doi-asserted-by":"crossref","first-page":"H1702","DOI":"10.1152\/ajpheart.00101.2026","article-title":"Long-term genetic Orai1 inhibition modulates excitation-contraction coupling in female adult mouse ventricular cardiomyocytes","volume":"330","author":"Bartoli","year":"2026","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.cellsig.2026.112764_bb0180","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1093\/cvr\/cvx151","article-title":"Hierarchical statistical techniques are necessary to draw reliable conclusions from analysis of isolated cardiomyocyte studies","volume":"113","author":"Sikkel","year":"2017","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.cellsig.2026.112764_bb0185","doi-asserted-by":"crossref","DOI":"10.1007\/s00345-025-06140-z","article-title":"TERT expression in human prostate tissue reveals a potential molecular switch in benign prostatic hyperplasia progression","volume":"44","author":"Xu","year":"2025","journal-title":"World. J. Urol."},{"key":"10.1016\/j.cellsig.2026.112764_bb0190","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.euf.2024.04.006","article-title":"Benign prostatic hyperplasia surgery: a snapshot of trends, costs, and surgical retreatment rates in the USA","volume":"10","author":"Ditonno","year":"2024","journal-title":"Eur. Urol. Focus"},{"key":"10.1016\/j.cellsig.2026.112764_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.121289","article-title":"A lncRNA MALAT1 is a positive regulator of RhoA protein expression in bronchial smooth muscle cells","volume":"313","author":"Chiba","year":"2023","journal-title":"Life Sci."},{"key":"10.1016\/j.cellsig.2026.112764_bb0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0178574","article-title":"Diabetes-induced oxidative stress mediates upregulation of RhoA\/rho kinase pathway and hypercontractility of gastric smooth muscle","volume":"12","author":"Mahavadi","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.cellsig.2026.112764_bb0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035882","article-title":"Deletion of Dicer in smooth muscle affects voiding pattern and reduces detrusor contractility and neuroeffector transmission","volume":"7","author":"Sadegh","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.cellsig.2026.112764_bb0210","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.diff.2017.07.005","article-title":"Targeting phenotypic heterogeneity in benign prostatic hyperplasia","volume":"96","author":"Strand","year":"2017","journal-title":"Differentiation"},{"key":"10.1016\/j.cellsig.2026.112764_bb0215","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1124\/molpharm.121.000304","article-title":"ADP Ribosylation factor 6 promotes contraction and proliferation, suppresses apoptosis and is specifically inhibited by NAV2729 in prostate stromal cells","volume":"100","author":"Wang","year":"2021","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.cellsig.2026.112764_bb0220","article-title":"miR-16-5p mediates E2-induced cell proliferation and EMT in benign prostate hyperplasia","volume":"16","author":"Kim","year":"2026","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cellsig.2026.112764_bb0225","first-page":"5329","article-title":"MiR-29a suppresses prostate cell proliferation and induces apoptosis via KDM5B protein regulation","volume":"8","author":"Li","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"key":"10.1016\/j.cellsig.2026.112764_bb0230","doi-asserted-by":"crossref","first-page":"3993","DOI":"10.18632\/oncotarget.6540","article-title":"Exosomes from bulk and stem cells from human prostate cancer have a differential microRNA content that contributes cooperatively over local and pre-metastatic niche","volume":"7","author":"S\u00e1nchez","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.cellsig.2026.112764_bb0235","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.bbrc.2016.02.093","article-title":"MiR-26b inhibits autophagy by targeting ULK2 in prostate cancer cells","volume":"472","author":"John Clotaire","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cellsig.2026.112764_bb0240","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1446831","article-title":"Dynamic phenotypic shifts and M2 receptor downregulation in bladder smooth muscle cells induced by mirabegron","volume":"15","author":"Muderrisoglu","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.cellsig.2026.112764_bb0245","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.molimm.2016.09.004","article-title":"MiR-143-3p controls TGF-beta1-induced cell proliferation and extracellular matrix production in airway smooth muscle via negative regulation of the nuclear factor of activated T cells 1","volume":"78","author":"Cheng","year":"2016","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.cellsig.2026.112764_bb0250","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.cell.2014.03.055","article-title":"An essential mesenchymal function for miR-143\/145 in intestinal epithelial regeneration","volume":"157","author":"Chivukula","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.cellsig.2026.112764_bb0255","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1152\/physrev.00023.2003","article-title":"Ca2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase","volume":"83","author":"Somlyo","year":"2003","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.cellsig.2026.112764_bb0260","doi-asserted-by":"crossref","first-page":"F1383","DOI":"10.1152\/ajprenal.00380.2013","article-title":"The receptor antagonist picotamide inhibits adrenergic and thromboxane-induced contraction of hyperplastic human prostate smooth muscle","volume":"305","author":"Hennenberg","year":"2013","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.cellsig.2026.112764_bb0265","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/pros.23293","article-title":"Non-adrenergic, tamsulosin-insensitive smooth muscle contraction is sufficient to replace \u03b1(1) -adrenergic tension in the human prostate","volume":"77","author":"Hennenberg","year":"2017","journal-title":"Prostate"},{"key":"10.1016\/j.cellsig.2026.112764_bb0270","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.eururo.2013.01.018","article-title":"Systematic review of combination drug therapy for non-neurogenic male lower urinary tract symptoms","volume":"64","author":"F\u00fcllhase","year":"2013","journal-title":"Eur. Urol."},{"key":"10.1016\/j.cellsig.2026.112764_bb0275","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.eururo.2009.09.035","article-title":"The effects of combination therapy with dutasteride and tamsulosin on clinical outcomes in men with symptomatic benign prostatic hyperplasia: 4-year results from the CombAT study","volume":"57","author":"Roehrborn","year":"2010","journal-title":"Eur. Urol."},{"key":"10.1016\/j.cellsig.2026.112764_bb0280","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.juro.2007.09.084","article-title":"The effects of dutasteride, tamsulosin and combination therapy on lower urinary tract symptoms in men with benign prostatic hyperplasia and prostatic enlargement: 2-year results from the CombAT study","volume":"179","author":"Roehrborn","year":"2008","journal-title":"J. Urol."},{"key":"10.1016\/j.cellsig.2026.112764_bb0285","doi-asserted-by":"crossref","DOI":"10.1186\/s12894-015-0090-x","article-title":"Patient\u2019s adherence on pharmacological therapy for benign prostatic hyperplasia (BPH)-associated lower urinary tract symptoms (LUTS) is different: is combination therapy better than monotherapy?","volume":"15","author":"Cindolo","year":"2015","journal-title":"BMC Urol."},{"key":"10.1016\/j.cellsig.2026.112764_bb0290","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.eururo.2014.11.006","article-title":"Drug adherence and clinical outcomes for patients under pharmacological therapy for lower urinary tract symptoms related to benign prostatic hyperplasia: population-based cohort study","volume":"68","author":"Cindolo","year":"2015","journal-title":"Eur. Urol."},{"key":"10.1016\/j.cellsig.2026.112764_bb0295","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1002\/pros.23805","article-title":"Outcome of Botulinum Toxin-A intraprostatic injection for benign prostatic hyperplasia induced lower urinary tract symptoms: a prospective multicenter study","volume":"79","author":"Moussa","year":"2019","journal-title":"Prostate"},{"key":"10.1016\/j.cellsig.2026.112764_bb0300","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1002\/nau.23390","article-title":"Intraprostatic botulinum toxin type \u201cA\u201d injection in patients with benign prostatic hyperplasia and unsatisfactory response to medical therapy: a randomized, double-blind, controlled trial using urodynamic evaluation","volume":"37","author":"Totaro","year":"2018","journal-title":"Neurourol.Urodyn."},{"key":"10.1016\/j.cellsig.2026.112764_bb0305","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/pros.24819","article-title":"Safety and efficacy of intra-prostatic injection of betamethasone for refractory chronic nonbacterial prostatitis: a prospective cohort clinical study","volume":"85","author":"Abdelaziz","year":"2025","journal-title":"Prostate"},{"key":"10.1016\/j.cellsig.2026.112764_bb0310","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/iju.14541","article-title":"Intraprostatic prophylactic antibiotic injection in patients undergoing transrectal ultrasonography-guided prostate biopsy","volume":"28","author":"Shobeirian","year":"2021","journal-title":"Int. J. Urol."},{"key":"10.1016\/j.cellsig.2026.112764_bb0315","article-title":"Tissue distribution of ethanol after intraprostatic injection using a porous needle","volume":"12","author":"Eubank","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.cellsig.2026.112764_bb0320","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.eururo.2022.01.045","article-title":"European association of urology guidelines on the diagnosis and management of female non-neurogenic lower urinary tract symptoms. Part 1: diagnostics, overactive bladder, stress urinary incontinence, and mixed urinary incontinence","volume":"82","author":"Nambiar","year":"2022","journal-title":"Eur. Urol."},{"key":"10.1016\/j.cellsig.2026.112764_bb0325","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/s41434-021-00275-5","article-title":"rAAV-based and intraprostatically delivered miR-34a therapeutics for efficient inhibition of prostate cancer progression","volume":"29","author":"Ai","year":"2022","journal-title":"Gene Ther."},{"key":"10.1016\/j.cellsig.2026.112764_bb0330","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2022.884057","article-title":"Inhibition of human prostate and bladder smooth muscle contraction, vasoconstriction of porcine renal and coronary arteries, and growth-related functions of prostate stromal cells by presumed small molecule G\u03b1(q\/11) inhibitor, YM-254890","volume":"13","author":"Tamalunas","year":"2022","journal-title":"Front. Physiol."}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656826004213?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656826004213?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T11:40:56Z","timestamp":1787053256000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0898656826004213"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":66,"alternative-id":["S0898656826004213"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2026.112764","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"miR-143-3p integrates contractility and growth in benign prostate stromal cells","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2026.112764","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"112764"}}